Aesthetic Performance of Two Injectable Resin Composites in Class V Cavities: A Randomized Clinical Trial

ConditionRestoration of Carious Class v Anterior Teeth

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age20-60

SponsorFuture University in Egypt

About this trial

Using bioactive injectable resin composite in anterior class v carious lesions can provide better aesthetic outcome and marginal integrity by releasing multiple ions, including fluoride. This offers better marginal integrity due to presence of S-PRG fillers

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 20-60 years.

Co-operative participants approving to participate in the study.

Male or female patients.

Medically free participants.

Disqualifiers

Systemic disease or severe medical complications.

Participants with a history of allergy to any component of restorations will be used in the study.

Lack of compliance

Evidence of severe bruxism, clenching, or temporomandibular joint disorders or bizarre habits

Trial design

Design model

Parallel

Treatments tested in this trial

Giomer based injectable composite
Procedure/Surgery
Giomers utilize surface pre-reacted glass (SPRG) technology, which involves an acid-base reaction between fluorine-containing glass particles and polymer-containing acid when exposed to water. This reaction results in the formation of a glass ionomer phase, which is then dispersed throughout the resin. Furthermore, the S-PRG fillers present in giomer materials enable the continuous release and replenishment of fluoride, offering long-lasting protection against the recurrence of caries
Universal injectable resin composite
Procedure/Surgery
Conventional injectable resin composite

Treatment groups

50 Participants

are divided into 2 treatment groups

Group A: Beautifil flow plus x f00Active comparator 1 intervention

Group B: G-aenial universal injectable resin compositeActive comparator 1 intervention

Trial outcomes

Primary outcomes

Marginal discoloration using FDI criteria

Time frame

12 Month

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Future University in Egypt

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: